#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Univentricular heart Marfan's syndrome Pulmonary alveolar haemorrhage Meningitis meningococcal Ewing's sarcoma metastatic Acute myeloid leukaemia recurrent Neurodegenerative disorder Keratosis follicular Chronic graft versus host disease Becker's muscular dystrophy Peripheral T-cell lymphoma unspecified Hodgkin's disease Nodal marginal zone B-cell lymphoma Transient ischaemic attack Restless legs syndrome More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Life with Disease Nephrotic syndrome – Trials in Disease Marfan’s syndrome Haemophilia B with anti factor IX – Trials in Disease Prolymphocytic leukaemia – Basic Information Thrombotic thrombocytopenic purpura – Diagnostics Optic glioma Congenital nephrogenic diabetes insipidus – Life with Disease Angiosarcoma metastatic – Diagnostics Shprintzen-Goldberg syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meropenem Anhydrous SP16 Guanabenz Acetate Mps-214 BIIB115 SODIUM HYDROXIDE VX-993 Sotalol Hydrochloride Vsf1.01 Pancreas Powder Zamtocabtagene Autoleucel Bi 1015550 Progesterone, Micronised Festuca Rubra Pollen Calcium Oxybate H2-Receptor Antagonist Sodium Nitroprusside Dihydrate Zanubrutinib Ifezuntirgene Inilparvovec Linerixibat More therapies…

    Learn about Your Condition

    Precocious puberty Foot deformity Bacterial prostatitis Giardiasis Angiosarcoma non-metastatic Small for dates baby T-cell lymphoma Colorectal cancer stage III Varicella Metachromatic leukodystrophy Chronic sinusitis Traumatic pain Uveitis Neonatal anoxia Radius fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Randomized phase III adjuvant capecitabine plus temozolomide versus surveillance in patients with resected stage I‑III pancreatic neuroendocrine tumors

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Temozolomide
    • Capecitabine
    France

  • Safety and early efficacy of TranspoCART19 CAR‑T CD19 therapy in patients with refractory lupus nephritis (Phase I‑IIa)

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Transpocart19
    Spain

  • Long‑term safety study of S68587 (allogeneic CD19 CAR T‑cells with TRAC and CD52 disruption) in patients with advanced lymphoid leukemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    France

  • Phase 1/2 Study of VS-7375 with Drug Combination in Patients with Advanced KRAS G12D‑Mutated Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cetuximab
    • Pemetrexed
    Belgium France Germany Italy The Netherlands Spain

  • Efficacy of colistimethate sodium and ciprofloxacin for eradicating primary Pseudomonas aeruginosa infection in adults with bronchiectasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Ciprofloxacin
    • Sodium Chloride
    Spain

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Spain
Previous Page
1 … 696 697 698 699 700 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!